EHA26: Epcoritamab improves PFS but not OS in R/R LBCL

Monday, June 15, 2026GlobalData HealthcareView original

The Phase III EPCORE DLBCL-1 met one of the two endpoints, with Genmab set to discuss next steps with global regulatory authorities.

Read the full article on the original site.